Constant high adrenal FDG uptake in PET/CT associated with mitochondrial disease

Mika H Martikainen1, Ulla Hohenthal, Laura Pirilä

  • 1Division of Clinical Neurosciences, University of Turku and Turku University Hospital, Kiinamyllynkatu 4-8, 20520, Turku, Finland, mikmar@utu.fi.

Insights

A patient with m.3243A>G mitochondrial DNA mutation and Streptococcus constellatus sepsis showed high adrenal gland (18)F-FDG uptake. This indicates significant metabolic stress, persisting even six months post-sepsis, linked to the underlying mitochondrial disorder.

Area of Science:

  • Mitochondrial genetics
  • Infectious disease
  • Nuclear medicine imaging

Background:

  • The m.3243A>G mitochondrial DNA mutation is associated with various organ dysfunctions.
  • Sepsis triggers a systemic hypermetabolic state.
  • Positron emission tomography (PET) with fluorodeoxyglucose (FDG) is used to assess metabolic activity.

Observation:

  • A patient with the m.3243A>G mutation developed Streptococcus constellatus sepsis.
  • Acute phase imaging revealed abnormally high (18)F-FDG uptake in anatomically normal adrenal glands.
  • Repeated imaging six months later showed diminished but still elevated adrenal (18)F-FDG uptake.

Findings:

  • Unlike 30 patients with Staphylococcus aureus sepsis, this patient exhibited significant adrenal (18)F-FDG uptake during sepsis.
  • The high adrenal uptake likely reflects acute metabolic stress from infection in the context of mitochondrial disease.
  • Persistently elevated adrenal uptake suggests chronic metabolic stress linked to the mitochondrial disorder.

Implications:

  • This case highlights the potential for heightened adrenal metabolic stress in patients with mitochondrial DNA mutations during sepsis.
  • FDG-PET imaging may offer insights into the metabolic consequences of mitochondrial disorders during infectious episodes.
  • Further research is warranted to understand the long-term metabolic impact on adrenal glands in this patient population.